Ledger.Open graph →
SEC Form D · Amendment · filed August 20, 2024

Ambrosia Biosciences Inc

Offering
$25.0M
Sold
$16.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BOULDER, CO
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Nicholas Traggis · Boulder, COExec · DirectorDavid S. Snitman · Boulder, CODirectorKyle J. Lefkoff · Boulder, CODirectorWilliam S. Marshall · Boulder, CODirectorJohn S. Orwin · Boulder, CODirectorDavid S. Snitman · Boulder, CODirectorJohn S. Orwin · Boulder, CODirectorMark D. O'Sullivan · NEW YORK, NYDirectorWilliam S. Marshall · Boulder, CODirectorNicholas Traggis · Boulder, COExec · DirectorKindal Kreamer · New York, NYDirectorRichard Baur · St Louis, MODirectorAlatus Capital LLC · Geneva, V8DirectorConner Thomas · SAN FRANCISCO, CAExec · DirectorDonald J. Rogers · WESTPORT, CTDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗